31
Pharma & HealthcareAvoid
LIC MF Healthcare
LIC · Direct–Growth · rank #16 of 19 by Smart Score
Data updated
Trailing returns
1 Year
18.3%
+17.6% vs index
3 Years
21.4%
+9.9% vs index
5 Years
14.8%
+4.7% vs index
Since launch
19.2%
Year-by-year performance
2024
+43.9%+28.3% vs index
2025
-3.2%-10.9% vs index
2026
+21.4%+20.5% vs index
Why this score
LIC MF Healthcare scores 31/100 — #16 of 19 Pharma & Healthcare fund (Avoid). The main drag is its 5y return (better than only 5% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return14.76% · 5th percentile in category
Fund size96.69 Cr · 3rd percentile in category
Expense ratio1.38% · 14th percentile in category
Volatility16.16 · 28th percentile in category
Alpha2.60 · 28th percentile in category
1Y return18.31% · 32nd percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd8.65%
2.Divi's Laboratories Ltd7.09%
3.Apollo Hospitals Enterprise Ltd6.13%
4.Torrent Pharmaceuticals Ltd5.97%
5.Neuland Laboratories Ltd5.83%
27 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.